March 2, 2020 / 1:57 PM / a month ago

BRIEF-Intra-Cellular Therapies Reports Q4 Loss Per Share Of $0.74

March 2 (Reuters) - Intra-Cellular Therapies Inc:

* INTRA-CELLULAR THERAPIES REPORTS FOURTH QUARTER AND FULL-YEAR 2019 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

* Q4 LOSS PER SHARE $0.74

* Q4 EARNINGS PER SHARE ESTIMATE $-0.81 — REFINITIV IBES DATA

* PREPARATIONS FOR COMMERCIAL LAUNCH OF CAPLYTA LATER THIS MONTH ARE FULLY ON TRACK Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below